By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian firm Genetic Technologies today reported that its revenues increased 111 percent for the year ended June 30, 2011, while it posted a profit for the first time.

Its revenues totaled A$18.3 million (US$19.2 million) versus A$8.7 million for the previous fiscal year. Genetic Technologies said that the increase was primarily due to a 266 percent increase in revenue from its out-licensing program, which granted 11 new licenses during the year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more